Data from the Hong Kong Stock Exchange reveals that on August 28, Fullgoal Fund Management Co., Ltd. increased its shareholding in BIOCYTOGEN-B (02315) by 536,000 shares.
The shares were acquired at a price of HK$60.1705 each, bringing the total transaction value to approximately HK$32.2514 million.
Following this purchase, Fullgoal's latest share count in the company stands at approximately 9.1861 million shares, lifting its ownership ratio to 8.29%.